Study aims to assess bleeding complications in patients undergoing high-risk percutaneous coronary interventions

A new multi-center, single-arm, open-label study is the first to exclusively assess bleeding complications in patients undergoing high-risk percutaneous coronary interventions (PCI) with Impella with independent adjudication via a clinical events adjudication committee and will gather meaningful real-world data based on contemporary practice. The design and rationale of the study was published online in the Journal of the Society for Cardiovascular Angiography & Interventions.